Stock Screener
Stock Research
Delisted Stocks
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Taro Pharmaceutical Industries Operating Income 2010-2023 | TARO

Taro Pharmaceutical Industries operating income from 2010 to 2023. Operating income can be defined as income after operating expenses have been deducted and before interest payments and taxes have been deducted.
  
Taro Pharmaceutical Industries Annual Operating Income
(Millions of US $)
2024 $21
2023 $18
2022 $63
2021 $-414
2020 $247
2019 $296
2018 $303
2017 $515
2016 $614
2015 $528
2014 $430
2013 $329
2012 $66
2011 $
2011 $33
2010 $
2010 $17
2009 $-9
Taro Pharmaceutical Industries Quarterly Operating Income
(Millions of US $)
2023-12-31 $16
2023-09-30 $5
2023-06-30 $-8
2023-03-31 $9
2022-12-31 $1
2022-09-30 $-7
2022-06-30 $14
2022-03-31 $21
2021-12-31 $37
2021-09-30 $24
2021-06-30 $-19
2021-03-31 $-42
2020-12-31 $36
2020-09-30 $41
2020-06-30 $-449
2020-03-31 $57
2019-12-31 $58
2019-09-30 $63
2019-06-30 $69
2019-03-31 $75
2018-12-31 $79
2018-09-30 $79
2018-06-30 $63
2018-03-31 $75
2017-12-31 $62
2017-09-30 $89
2017-06-30 $78
2017-03-31 $102
2016-12-31 $129
2016-09-30 $142
2016-06-30 $143
2016-03-31 $182
2015-12-31 $173
2015-09-30 $125
2015-06-30 $134
2015-03-31 $160
2014-12-31 $159
2014-09-30 $160
2014-06-30 $48
2014-03-31 $99
2013-12-31 $135
2013-09-30 $122
2013-06-30 $74
2013-03-31 $63
2012-12-31 $104
2012-09-30 $82
2012-06-30 $79
2012-03-31 $66
2011-12-31 $75
2011-09-30 $62
2011-06-30 $34
2011-03-31 $33
2010-12-31 $24
2010-09-30 $24
2010-06-30 $20
2010-03-31 $17
2009-12-31 $15
2009-09-30 $17
2009-06-30 $21
2009-03-31
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $1.615B $0.629B
Taro Pharmaceutical Industries is engaged in the production, research and development, and marketing of prescription and over-the-counter pharmaceutical products, with a focus on generic products. In addition to the production of finished dosage form drugs, they also synthesize the pharmaceutical chemicals used in their production. Products are sold through wholesalers, generic drug distributors, drug store chains, mass merchandisers, HMOs, food stores, pharmacies and hospitals.
Stock Name Country Market Cap PE Ratio
Zoetis (ZTS) United States $78.068B 31.74
Chugai Pharmaceutical (CHGCY) Japan $52.837B 23.62
Takeda Pharmaceutical (TAK) Japan $39.877B 8.08
Merck (MKGAF) Germany $22.533B 21.85
Astellas Pharma (ALPMY) Japan $17.228B 27.20
Sandoz Group AG (SDZNY) Switzerland $15.846B 0.00
United Therapeutics (UTHR) United States $14.018B 14.94
Neurocrine Biosciences (NBIX) United States $13.543B 37.07
Shionogi (SGIOY) Japan $11.091B 9.64
Catalent (CTLT) United States $10.225B 0.00
Cerevel Therapeutics Holdings (CERE) United States $7.588B 0.00
Jazz Pharmaceuticals (JAZZ) Ireland $6.809B 7.48
Revolution Medicines (RVMD) United States $6.304B 0.00
Ionis Pharmaceuticals (IONS) United States $6.106B 0.00
Orion OYJ (ORINY) Finland $6.014B 25.36
Madrigal Pharmaceuticals (MDGL) United States $5.934B 0.00
Summit Therapeutics (SMMT) United States $5.567B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $5.561B 0.00
Crinetics Pharmaceuticals (CRNX) United States $3.594B 0.00
Arrowhead Pharmaceuticals (ARWR) United States $3.167B 0.00
Corcept Therapeutics (CORT) United States $3.127B 28.34
Dyne Therapeutics (DYN) United States $3.060B 0.00
PTC Therapeutics (PTCT) United States $2.801B 0.00
Indivior (INDV) United States $2.315B 10.97
Recursion Pharmaceuticals (RXRX) United States $2.103B 0.00
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.053B 11.67
Catalyst Pharmaceuticals (CPRX) United States $1.841B 17.92
NewAmsterdam Pharma (NAMS) Netherlands $1.621B 0.00
Evotec AG (EVO) Germany $1.588B 0.00
Avadel Pharmaceuticals (AVDL) Ireland $1.443B 0.00
Ardelyx (ARDX) United States $1.433B 0.00
Soleno Therapeutics (SLNO) United States $1.375B 0.00
Pacira BioSciences (PCRX) United States $1.334B 12.68
BioCryst Pharmaceuticals (BCRX) United States $1.325B 0.00
Xencor (XNCR) United States $1.221B 0.00
4D Molecular Therapeutics (FDMT) United States $1.186B 0.00
Calliditas Therapeutics AB (CALT) Sweden $1.154B 0.00
Collegium Pharmaceutical (COLL) United States $1.036B 6.20
Enliven Therapeutics (ELVN) United States $1.008B 0.00
Ocular Therapeutix (OCUL) United States $0.968B 0.00
Cassava Sciences (SAVA) United States $0.960B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.953B 14.85
Relay Therapeutics (RLAY) United States $0.921B 0.00
Centessa Pharmaceuticals (CNTA) United Kingdom $0.914B 0.00
Cronos Group (CRON) Canada $0.890B 0.00
USANA Health Sciences (USNA) United States $0.868B 14.20
ARS Pharmaceuticals (SPRY) United States $0.792B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $0.789B 0.00
Harrow (HROW) United States $0.743B 0.00
Sage Therapeutics (SAGE) United States $0.670B 0.00
Exscientia (EXAI) United Kingdom $0.652B 0.00
Silence Therapeutics (SLN) United Kingdom $0.588B 0.00
ProKidney (PROK) United States $0.573B 0.00
Savara (SVRA) United States $0.536B 0.00
Lexeo Therapeutics (LXEO) United States $0.534B 0.00
Lyell Immunopharma (LYEL) United States $0.523B 0.00
Larimar Therapeutics (LRMR) United States $0.519B 0.00
KalVista Pharmaceuticals (KALV) United States $0.495B 0.00
Heron Therapeutics (HRTX) United States $0.487B 0.00
Siga Technologies (SIGA) United States $0.474B 6.05
OmniAb (OABI) United States $0.469B 0.00
Altimmune (ALT) United States $0.454B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.454B 0.00
Bioventus (BVS) United States $0.449B 17.18
Verve Therapeutics (VERV) United States $0.444B 0.00
Theravance Biopharma (TBPH) Cayman Islands $0.426B 0.00
Esperion Therapeutics (ESPR) United States $0.419B 0.00
Tourmaline Bio (TRML) United States $0.392B 0.00
Organogenesis (ORGO) United States $0.331B 62.50
Korro Bio (KRRO) United States $0.328B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.316B 0.00
Xeris Biopharma Holdings (XERS) United States $0.313B 0.00
Nature's Sunshine Products (NATR) United States $0.282B 17.91
Black Diamond Therapeutics (BDTX) United States $0.272B 0.00
Enanta Pharmaceuticals (ENTA) United States $0.253B 0.00
Eliem Therapeutics (ELYM) United States $0.247B 0.00
Century Therapeutics (IPSC) United States $0.242B 0.00
Aquestive Therapeutics (AQST) United States $0.233B 0.00
Foghorn Therapeutics (FHTX) United States $0.226B 0.00
Incannex Healthcare (IXHL) Australia $0.222B 0.00
Profound Medical (PROF) Canada $0.217B 0.00
ESSA Pharma (EPIX) Canada $0.217B 0.00
Fractyl Health (GUTS) United States $0.216B 0.00
Nektar Therapeutics (NKTR) United States $0.213B 0.00
Avita Medical (RCEL) United States $0.211B 0.00
Prelude Therapeutics (PRLD) United States $0.210B 0.00
Aldeyra Therapeutics (ALDX) United States $0.207B 0.00
Acrivon Therapeutics (ACRV) United States $0.204B 0.00
Innate Pharma SA (IPHYF) France $0.200B 0.00
Pyxis Oncology (PYXS) United States $0.198B 0.00
Nanobiotix S.A (NBTX) France $0.196B 0.00
Akebia Therapeutics (AKBA) United States $0.191B 0.00
Zevra Therapeutics (ZVRA) United States $0.182B 0.00
Elite Pharmaceuticals (ELTP) United States $0.176B 16.50
Adherex Technologies (FENC) United States $0.175B 214.00
Achieve Life Sciences (ACHV) Canada $0.171B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.167B 0.00
Regulus Therapeutics (RGLS) United States $0.164B 0.00
Context Therapeutics (CNTX) United States $0.162B 0.00
Telomir Pharmaceuticals (TELO) United States $0.155B 0.00
Galectin Therapeutics (GALT) United States $0.145B 0.00
CytoDyn (CYDY) United States $0.139B 0.00
Metagenomi (MGX) United States $0.134B 0.00
Cardiol Therapeutics (CRDL) Canada $0.126B 0.00
MediWound (MDWD) Israel $0.125B 0.00
VAXART, INC (VXRT) United States $0.125B 0.00
OptiNose (OPTN) United States $0.123B 0.00
Karyopharm Therapeutics (KPTI) United States $0.122B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.121B 8.09
Conduit Pharmaceuticals (CDT) United States $0.115B 0.00
FibroGen (FGEN) United States $0.112B 0.00
Citius Pharmaceuticals (CTXR) United States $0.110B 0.00
Assertio Holdings (ASRT) United States $0.109B 5.00
Journey Medical (DERM) United States $0.104B 0.00
Relmada Therapeutics (RLMD) United States $0.091B 0.00
ARYA Sciences Acquisition Corp IV (ARYD) United States $0.086B 0.00
AlloVir (ALVR) United States $0.086B 0.00
ProPhase Labs (PRPH) United States $0.084B 0.00
PMV Pharmaceuticals (PMVP) United States $0.083B 0.00
Aclaris Therapeutics (ACRS) United States $0.082B 0.00
Arch Biopartners (ACHFF) $0.077B 0.00
SCYNEXIS (SCYX) United States $0.074B 1.04
Marinus Pharmaceuticals (MRNS) United States $0.073B 0.00
Vivani Medical (VANI) United States $0.069B 0.00
Champions Oncology (CSBR) United States $0.068B 0.00
Nutriband (NTRB) United States $0.057B 0.00
Mural Oncology (MURA) Ireland $0.055B 0.00
Reneo Pharmaceuticals (RPHM) United States $0.054B 0.00
CASI Pharmaceuticals (CASI) China $0.049B 0.00
Lipocine (LPCN) United States $0.048B 0.00
BioLineRx (BLRX) Israel $0.047B 0.00
DURECT (DRRX) United States $0.047B 0.00
Inotiv (NOTV) United States $0.047B 0.00
Protara Therapeutics (TARA) United States $0.047B 0.00
Tempest Therapeutics (TPST) United States $0.045B 0.00
Carisma Therapeutics (CARM) United States $0.042B 0.00
Natural Alternatives (NAII) United States $0.040B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.038B 0.00
Rafael Holdings (RFL) United States $0.035B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.035B 0.00
Surrozen (SRZN) United States $0.031B 0.00
BioVie (BIVI) United States $0.029B 0.00
Enlivex Therapeutics (ENLV) Israel $0.028B 0.00
NRx Pharmaceuticals (NRXP) United States $0.028B 0.00
VYNE Therapeutics (VYNE) United States $0.026B 0.00
Viracta Therapeutics (VIRX) United States $0.025B 0.00
Oncternal Therapeutics (ONCT) United States $0.024B 0.00
Minerva Neurosciences (NERV) United States $0.024B 0.00
Unicycive Therapeutics (UNCY) United States $0.024B 0.00
Aptorum Group (APM) United Kingdom $0.024B 0.00
Gain Therapeutics (GANX) United States $0.023B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.023B 0.00
TherapeuticsMD (TXMD) United States $0.022B 0.00
SHINECO (SISI) China $0.022B 0.00
Iterum Therapeutics (ITRM) Ireland $0.021B 0.00
PolyPid (PYPD) Israel $0.020B 0.00
JanOne (JAN) United States $0.020B 0.00
Jaguar Animal Health (JAGX) United States $0.019B 0.00
Indaptus Therapeutics (INDP) United States $0.019B 0.00
MEI Pharma (MEIP) United States $0.019B 0.73
GlycoMimetics (GLYC) United States $0.017B 0.00
Nuvilex (PMCB) United States $0.016B 0.00
Lyra Therapeutics (LYRA) United States $0.016B 0.00
Talphera (TLPH) United States $0.016B 0.00
Avalo Therapeutics (AVTX) United States $0.013B 0.00
Mannatech (MTEX) United States $0.013B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.012B 0.00
Traws Pharma (TRAW) United States $0.012B 0.00
Cosmos Health (COSM) Greece $0.011B 0.00
Dominari Holdings (DOMH) United States $0.011B 0.00
Alaunos Therapeutics (TCRT) United States $0.011B 0.00
Redhill Biopharma (RDHL) Israel $0.011B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.011B 0.00
Plus Therapeutics (PSTV) United States $0.010B 0.00
Inhibikase Therapeutics (IKT) United States $0.010B 0.00
Universe Pharmaceuticals INC (UPC) China $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.008B 0.00
Mangoceuticals (MGRX) United States $0.008B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Vivos Therapeutics (VVOS) United States $0.007B 0.00
Molecular Templates (MTEM) United States $0.007B 0.00
Xenetic Biosciences (XBIO) United States $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.006B 0.00
Heatwurx (PCSA) United States $0.006B 0.00
Ainos (AIMD) United States $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.005B 0.00
MyMD Pharmaceuticals (MYMD) United States $0.004B 0.00
Bio-Path Holdings (BPTH) United States $0.004B 0.00
XORTX Therapeutics (XRTX) Canada $0.004B 0.00
Tonix Pharmaceuticals Holding (TNXP) United States $0.004B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.003B 0.00
Avenue Therapeutics (ATXI) United States $0.003B 0.00
Phio Pharmaceuticals (PHIO) United States $0.003B 0.00
Petros Pharmaceuticals (PTPI) United States $0.003B 0.00
Clearmind Medicine (CMND) Canada $0.002B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.002B 0.00
InMed Pharmaceuticals (INM) Canada $0.002B 0.00
Altamira Therapeutics (CYTO) Bermuda $0.002B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.002B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Qualigen Therapeutics (QLGN) United States $0.001B 0.00
PainReform (PRFX) Israel $0.001B 0.00
SciSparc (SPRC) Israel $0.001B 0.00
China SXT Pharmaceuticals (SXTC) China $0.000B 0.00
Aditxt (ADTX) United States $0.000B 0.00
Qilian Holding Group (QLI) China $0.000B 0.00
Grifols, S.A (GRFS) Spain $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.000B 0.00
Procaps Group, S.A (PROC) Luxembourg $0.000B 5.17
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Stevanato Group S.p.A (STVN) Italy $0.000B 30.15